Tumor Suppressor Par-4 -

Tumor Suppressor Par-4

Structural Features, Molecular Mechanisms and Function

Vivek M. Rangnekar (Herausgeber)

Buch | Hardcover
X, 323 Seiten
2022 | 1st ed. 2022
Springer International Publishing (Verlag)
978-3-030-73571-5 (ISBN)
181,89 inkl. MwSt
Par-4 is a tumor suppressor protein first discovered and identified in 1993 by Dr. Vivek Rangnekar's laboratory in prostate cancer cells undergoing apoptosis.  Par-4 (later also known as PAWR) is a naturally occurring tumor suppressor. Studies have indicated that Par-4 selectively induces apoptosis in cancer cells while leaving normal, healthy, cells unaffected. Mechanisms contributing to the cancer-selective action of Par-4 have been associated with protein kinase A activation of intracellular Par-4 in cancer cells or GRP78 expression primarily on the surface of cancer cells. Par-4 is downregulated, inactivated or mutated in diverse cancers. This first of two volumes will be the first on the market on the topic of Par-4, and will provide the opportunity for researchers to discuss the future direction of studies, broaden the scope of research, and contribute a more complete understanding of the molecule's structural features, key functional domains, regulation and relevant basic and clinical/translational facets.

lt;b> Vivek M. Rangnekar, Ph.D. is Professor and Alfred Cohen Chair in Oncology Research in the Department of Radiation Medicine and Associate Director of the Markey Cancer Center at the University of Kentucky. His laboratory studies the molecular cross-talk between oncogenes and tumor suppressor genes in an effort to tilt the balance in favor of tumor suppressor function. Dr. Rangnekar originally discovered and identified the tumor suppressor protein Par-4/PAWR in 1993. 

Discovery and Overview of Par-4.- Par-4 in cell cycle regulation.- Conformational studies of the Par-4 C-terminal Domain.- Structural analysis of Par-4 and crystallographic analysis of the regulatory domain.- Regulation of Par-4 by Ubiquitinases.- REGULATION OF PAR-4 FUNCTION BY PHOSPHORYLATION.- Role of Par-4 in GRP78 translocation.- PAR-4 in the regulation of stem cell death and embryo development.- RASSF2 and the PAR-4 connection.- Regulation of tumor suppressor Par-4 by ceramide.- PAWR as a direct SRC-1/HOXC11 suppression target.- Index.

Erscheinungsdatum
Zusatzinfo X, 323 p. 84 illus., 81 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 661 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Studium
Schlagworte Amida • Apoptosis • Cancer cells • cell surface receptor GRP78 • clinical trial • DAPK • FDA-approved drugs • par-4 • PKA • Prostate • Protein • Stem Cells • THAP1 • Translational research • Zebrafish
ISBN-10 3-030-73571-0 / 3030735710
ISBN-13 978-3-030-73571-5 / 9783030735715
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
36,00